Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition

Current strategies for intratumoural immunotherapy – Beyond immune checkpoint inhibition

Immunotherapy has revolutionised most cancers therapy by restoration of host antitumour immune response. Immune checkpoint inhibitors (ICIs) confer sturdy responses in solely a subset of sufferers. Mechanisms of ICI resistance to enhance sturdy response charges and total survival are an space of intense scientific analysis. Sturdy scientific growth is ongoing to guage novel mixture therapies…

Read More